Barbiturates and the volatile anesthetic isoflu rane reduce CMR to similar values. If the mechanism of barbiturate protection against focal ischemic injury is due to a reduction in cellular energy requirements. then iso flurane should similarly reduce ischemic injury. To eval
uate this, spontaneously hypertensive rats underwent 2 h of reversible middle cerebral artery occlusion (MCAO) while receiving deep methohexital. isoflurane. or halo thane anesthesia. Ninety-six hours postischemia, neuro logic deficits were present but without a difference be tween groups. Mean ± SD infarct volume, as assessed by triphenyl tetrazolium chloride staining and computerized planimetry, was significantly less in the methohexital group (n = 8; 166 ± 74 mm 3 ) than in either the halothane (n = 9; 249 ± 71 mm 3 ; p < 0. 04) or the isoflurane (n = 9; 243 ± 62 mm 3 ; p < 0. 03) groups. One possible explana tion for the lack of protective effect for isoflurane might be related to its vasodilative properties, which could re sult in a cerebral vascular steal. To examine this possi bility, rats anesthetized with methohexital or isoflurane Barbiturates produce a dose-dependent decrease in CMR, having maximal effect at the end-point of EEG burst suppression (Michenfelder, 1974) . The same agents have also been demonstrated to pro vide cerebral protection in various animal models of focal ischemia (Smith et ai., 1974; Michenfelder et ai., 1976; Nehls et ai., 1987) . The presumed mech anism of this protection is a barbiturate-induced re duction in cerebral metabolic requirements that counterbalances diminished 02/substrate delivery. underwent autoradiographic determination of CBF with or without MCAO. In isoflurane-anesthetized sham rats (n = 5; no ischemia), CBF was approximately three times greater than in methohexital-treated (n = 5) sham rats. During ischemia. although a regional reduction in flow was noted in both anesthetic groups. mean flow remained greater in the isoflurane group. When the ischemic hemi sphere was analyzed for percentage of cross-sectional area where flow was <25 m1l100 g/min, significantly less tissue appeared to be at risk for infarction in the isoflu rane group (n = 7; 32.9 ± 19.4%) versus the methohexital group (n = 8; 49.1 ± 12.6%; p < 0. 05). These results are consistent with the following conclusions: (a) CMR re duction is not a sufficient criterion for anesthetic mediated brain protection; (b) isoflurane does not cause cerebrovascular steal; and (c) ischemic flow thresholds for infarction are different for methohexital and isoflu rane. Key Words: Anesthetics, inhalational and intrave nous-Brain-Cerebral blood flow-Halothane-Iso flurane-Methohexital.
Because the volatile anesthetic isoflurane produces a similar reduction in CMR (Newberg et ai., 1983; Warner et ai., 1989) , it has been suggested that it too might reduce tissue damage resulting from a transient episode of focal ischemia. We therefore evaluated the relative effects of deep methohexital, isoflurane, and halothane anesthesia on outcome from a 2-h episode of middle cerebral artery (MCA) occlusion (MCAO) in the rat.
METHODS Experiment 1: infarct volume
Surgical preparation and ischemia. This study was ap proved by our institutional Animal Care and Use Com mittee. Fasted male spontaneously hypertensive rats (age 13-14 weeks; Charles River) were anesthetized with 1-3% halothane in 30% 02/balance air, endotracheally in tubated, and mechanically ventilated to produce normo capnia and normoxia. Via surgical incisions, the tail ar-tery was cannulated for measurement of blood pressure and the right internal jugular vein was cannulated with a Silastic catheter filled with heparinized saline. A left sub temporal craniectomy was then performed (Shigeno et aI., 1985; Warner et aI., 1989) . With the aid of an operat ing microscope, the dura was opened and the left MCA was identified. Just distal to the lenticulostriate artery, the MCA was loosely encircled with a 10-0 suture (Ethilon monofilament nylon taper 2870 G 3/8 Circle BV75-3 needle; Ethicon, Somerville, NJ, U.S.A.). Bipa rietal EEG needle electrodes were percutaneously placed adjacent to the skull and a reference needle electrode was placed subcutaneously in the snout. A 24-g needle therm istor was also placed adjacent to the skull, and thereafter pericranial temperature was servo-regulated at 37.0 ± O.loC. Pancuronium, given intravenously as 0.5-mg bo lus, was repeated as necessary for control of ventilation. Following preparation, all rats received 50 I U heparin i.v. An overall interval of I h was allowed to complete these tasks.
Rats were then randomly assigned to one of three ex perimental groups based on the agent used for subsequent anesthesia. In Group I (n = 10), halothane was continued at a delivered concentration of 1.5% (1.3 MAC) (White et aI., 1974) . In the remaining animals (Groups 2 and 3), the halothane was discontinued. In Group 2 (n = 10), a con tinuous infusion of methohexital (500 mg in 20 ml 0.9% NaCl) was begun, the rate being adjusted to produce an EEG pattern of burst suppression (interburst interval s IS s). After a methohexital loading infusion rate of 90 mg/kg/h, burst suppression was typically maintained with an infusion rate of 55 mg/kg/h. Equal volumes of 0.9% NaCI (1.3 ml) were infused into the other two groups over the same interval. The remaining animals (Group 3; n = 10) received, instead, isoflurane in a concentration suffi cient to also produce EEG burst suppression (interburst intervalS-IS s). This typically required an isoflurane con centration of 1.9-2.0% (�I .3 MAC) (White et aI., 1974) . Anesthetic gas concentrations were monitored by a med ical gas analyzer (Puritan-Bennett model 222, Wilming ton, MA, U.S.A.) sampling from the expiratory limb of the anesthesia circuit. The above three anesthetic states were achieved over a 30-min interval while ventilation was adjusted to provide blood gas values within a normal range. A total of 10 rats were entered into each experi mental group.
Thirty minutes after group assignment, the MCA was occluded in all rats. A single-pass instrument tie of the 10-0 suture provided occlusion but allowed later release and reperfusion. Absence of flow was visually verified by an observed blanching of the vessel distal to the ligature. The MCA remained occluded for 2 h with blood gases measured at hourly intervals. An arbitrary MABP range of 90-I 00 mm Hg was selected and MABP was held within this range by bleeding or infusion of homologous donor rat whole blood as necessary. During MCAO the scalp wound was loosely closed with suture.
Upon completion of the 2-h ischemic interval, the MCA ligature was removed and reflow documented by visual observation of reexpansion of the MCA lumen. (Pilot studies had also been performed in five rats in which the identical procedure was followed. Immediately after re lease of the ligature, a bolus of methylene blue was given intravenously. In all rats this dye was observed to transit the full distance of the MCA under the operating micro scope.) Methohexital infusion was then discontinued while isoflurane or halothane anesthesia was continued in respective groups for an additional 50 min. This ensured that the total duration of anesthesia was similar for the three groups. During this interval, the temporalis and scalp were closed with suture. The venous and arterial catheters were removed and respective wounds closed. Upon discontinuation of anesthesia, the animals re mained ventilated until they were responsive to a light noxious stimulus and demonstrated satisfactory sponta neous respiratory efforts. The tracheas were then extu bated and the animals placed in an oxygen-enriched and warmed environment for 60 min. They were then re turned to cages with free access to ground pellet food and water for 4 days.
Neurologic evaluation. All rats were neurologically evaluated 96 h postischemia. For this, the neurologic scoring system described by Yamamoto et al. (1988) was employed. Neurological deficits were defined by the de gree of hemiplegia when the right legs of the rat were lifted up by a bar and by the degree of abnormal posture observed when the rats were lifted up by their tails. Each symptom was classified into three grades (0-2) by the following criteria: grade O-no neurologic deficits; grade I-mildly abnormal posture or mild hemiplegia; grade 2severely abnormal posture or severe hemiplegia. Total deficit score (0 = no deficits to 4 = severe deficits) was obtained by combining the abnormal posture and hemi plegia scores.
Evaluation of infarct volume. After neurologic evalua tion at 96 h postischemia, the animals were weighed, anesthetized with 4% halothane in 30% 02lbalance air, and decapitated. The brains were removed, cooled to 4°C for 10 min (to facilitate sectioning), and coronally cut into 2-mm-thick sections using a brain dissection block (Zivic Miller, Zelienople, PA, U.S.A.). The tissue was incu bated in a 37°C solution of 2% triphenyl tetrazolium chlo ride (Sigma) buffered to a pH of 7.40. This staining tech nique employs a colorimetric analysis for mitochondrial viability with viable tissue staining a crimson red and in farcted tissue white (Liszczak et aI., 1984; Bederson et aI., 1986) . Following incubation, the tissue sections were stored in a pH-buffered 4% formalin solution.
The stained serial brain sections were planimetrically evaluated for infarct volume. Each section was placed in a shallow saline bath under a television camera interfaced with a Digital Microvax II computer and a Gould image analyzer. The image was digitized according to optical density (reflectance) and the data stored as a matrix of pixel units. For each tissue section, the pixel units were calibrated, giving values as square millimeters. The digi tized image was then displayed on a video terminal and, with an operator-controlled cursor, the infarct border was outlined and infarct area determined. For each rat, infarct volume was computed as the running sum of infarct area times the 2-mm thickness of each section over the rostral caudal extent of the forebrain. Image analysis was per formed by individuals who were blinded to the experi mental condition.
Experiment 2: CBF Surgical preparation. After the results from Experi ment I were analyzed, we hypothesized that because of its vasodilative properties in normal vasculature, isoflu rane might be causing a steal of blood flow from higher resistance collateral circuits. To evaluate this possibility, spontaneously hypertensive rats were surgically prepared as described above while receiving halothane anesthesia. In addition, a femoral arterial catheter was placed. The halothane was then discontinued and the rats were ran domly assigned to receive isoflurane (n = 8) or metho hexital (n = 8) anesthesia as described above. In both cases, the dose of drug was adjusted to produce an EEG pattern of burst suppression. Again, a surgical prepara tion interval of I h was allowed, followed by a 30-min interval to establish the intended anesthetic state.
The MCA was then ligated as described in Experiment I. Cohort shams were also prepared in each anesthetic group (n = 5). These animals underwent craniotomy and opening of the dura, but no suture was passed around the MCA.
Determination ofCBF. One hour after MCAO (or after an equivalent waiting interval for the sham rats), final MABP and arterial blood gas values were recorded. 14 C_ Labeled iodoantipyrine (100 /1-Ci/kg; specific activity 60 mCilmmol; New England Nuclear, Boston, MA, U.S.A.) was infused intravenously at a constant rate over 45 s. During this time, 10 discontinuous 20-/1-1 arterial blood samples were collected for later determination of 14 C ac tivity. Upon completion of the isotope infusion, animals were decapitated, and the brains rapidly removed and frozen in n-pentane ( -5S OC).
Arterial blood samples were placed on chromatography paper and dried for 24 h. [ 14 C]-Iodoantipyrine was eluted by soaking the paper for an additional 24 h in a mixture of I ml water and 9 ml liquid scintillation cocktail (Ready SolvTM HP/b; Beckman, Fullerton, CA, U.S.A.). Radio activity was then determined by liquid scintillation count ing (model 6880; Searle, Des Plaines, IL, U.S.A.) using an external quench correction.
Frozen brains were cut in 20-/1-m-thick coronal sections on a cryostat at -20°C. Quadruplicate sections taken at 240-/1-m intervals were mounted on glass slides, dried for 5 min on a 50°C hotplate, and laid on Kodak-SB-5 auto radiographic film along with seven [ 14 C]methylmethacry late standards (Amersham, Arlington Hts., IL, U.S.A.). An exposure interval of 5-7 days was allowed. Images of six anatomically standardized brain sections (bregma + 1.2, +0.2, -1.3, -2.8, -3.8, -4.8 mm; levels 1-6 respectively-see Fig. 3 ) spanning the flow distribution of the MCA were chosen from each animal and converted to digitized optical density images using a scanning micro densitometer system (Eikonix-Kodak, Bedford, MA, U.S.A.) with a camera aperture of 100 /1-m and a fixed focal length. Tissue optical densities were converted to 14 C concentrations by comparison with the precalibrated standards, and this information along with arterial blood radioactivity data was entered into equations developed by Reivich et aI. (1969) and modified by Sakurada et aI. (1978) .
Individual CBF images from both lesioned and sham rats were pseudo-color enhanced and displayed on a cathode ray screen. Particular attention was directed to ward the left hemisphere (ipsilateral to the MCAO). With an operator-controlled cursor, regions of interest (ROIs) were circumscribed and average CBF for each ROI was calculated and recorded, along with the area of the ROI in pixel units. Three primary ROIs in each section were hemisphere, neocortex, and subcortex, where subcortex was defined as the hemispheric area minus the area of the cortical mantle (Hansen et aI., 1988) . Ventricular spaces were excluded from analysis. Secondary analysis, incor porating pixel-sorting techniques, allowed determination J Cereb Blood Flow Metab, Vol. 11, No.5, 1991 of the percentage of the cross-sectional area for each ROI in each section where flow values fell within the range of 0-25 ml/iOO g/min, All image analysis was performed by individuals who were blinded to the experimental condi tion.
Statistical analysis
Parametric data were analyzed by a one-or two-way analysis of variance where appropriate. When indicated by a significant F ratio, post hoc testing was performed with Fishers PLSD test. Neurologic scores were com pared by the Kruskal-Wallis H statistic, The relationship between infarct volume and neurologic score was com pared by the Spearman rank correlation coefficient. Val ues are reported as means ± SD. Significance was as sumed if p < 0.05.
RESULTS

Physiologic values
One rat from each group in Experiment I was found dead on the second or third day of the recov ery interval. Although the cause of death was not identified, physiologic values for these animals were within protocol and there was no evidence of intracranial hemorrhage in any of them. Physiologic values in surviving rats for which infarct volume was computed are presented in Table 1 . There were no significant intergroup differences for P aC02, P a02 ' arterial pH, plasma glucose, hematocrit, or MABP either prior to ischemia or after 1 or 2 h of ischemia. Intraischemic pericranial temperature was 37.0 ± O. 1 DC at all times, The balance between blood infused/withdrawn as required to maintain MABP similar during ischemia was different be tween all three groups (methohexital = -2.9 ± 1.0 ml; isotlurane = -0.9 ± 1.4 ml; halothane +0.8 ± 0.6 ml; p < 0.05). Preischemic body weight was similar between groups. Although there was a trend toward reduced body weight at 4 days postisch emia, this change did not reach significance nor was there a difference between groups. In Experiment 2, there were again no significant intergroup differences for Paco2, Pao2, arterial pH, hematocrit, or MABP either prior to ischemia or after I h (Table 2) or 2 h (not presented) of ischemia.
Neurology
Neurologic deficit scores recorded at 96 h post ischemia are presented in Fig. 1 for surviving rats. All rats in the methohexital and isoflurane groups were identified to have deficits. In all but one halo thane rat, deficits were also present. However, there were no differences between groups for this parameter.
Infarct volume
In one methohexital rat, tissue sectioning was technically inadequate, leaving eight animals avail able for analysis in this group and nine animals in each of the remaining groups. Infarcted tissue was consistently observed in the neocortex in all groups. While not independently quantitated, many of the rats also sustained subcortical injury almost exclusively restricted to the caudoputamen. No hemorrhagic infarcts were observed in any animal. Figure 2 illustrates individual total infarct volumes as identified by triphenyl tetrazolium chloride stain ing at 96 h post ischemia in surviving animals. Mean infarct volume was significantly less in the metho hexital group (166 ± 74 mm 3 ; n = 8) than in either the halothane (249 ± 71 mm 3 ; n = 9, p < 0.04) or the isoflurane (243 ± 62 mm 3 ; n = 9, p < 0.03) groups. There was no difference between the halo thane and isoflurane groups. There was not a sig nificant relationship between neurologic deficit score and infarct volume (Z = 0.55; p < 0.58) . 
CBF
Data from one isoflurane-treated MCAO rat were deleted owing to technical error. Blood flow values for each region of interest are listed in Table 3 for the remaining animals. Within the sham groups, blood flow values in the ipsilateral and contralateral hemispheric, neocortical, and subcortical ROIs were approximately three times greater during iso flurane as opposed to methohexital anesthesia (p < 0.001).
In rats undergoing MCAO, the different CBF ef fects of isoflurane versus methohexital were pre served in the contralateral hemisphere (p < 0.0 1). In the ipsilateral hemisphere, neocortical and hemi spheric blood flow values were significantly re duced in both anesthetic groups compared with re spective shams. Subcortical blood flow was also significantly reduced in isoflurane animals. Al though MCAO resulted in a 45% reduction in mean subcortical blood flow during methohexital anesthe- 
sia, this value did not reach significance (p < 0.06). Between anesthetic groups, however, blood flow in the ipsilateral hemisphere remained greater in all three regions during isoflurane versus methohexital anesthesia (p < 0.05). Figure 3 illustrates the percentage of the cross- sectional area within each ROI of the ipsilateral hemisphere where blood flow values were identified to be <25 mlllOO g/min. Values from each of the six anatomically standardized sections are provided. There was no significant difference between the two anesthetic agents in the sham groups with <5% of pixels falling within this flow range. In contrast, in sections taken from rats undergoing MCAO, �40-60% of the cross-sectional area had flow of <25 mllIOO g/min. The amount of tissue within this flow range was significantly less for isoflurane than for methohexital at all anatomic levels for the hemi spheric and cortical ROIs and in three of six sub cortical levels.
DISCUSSION
Despite current interest in nonanesthetic cerebral protectants including voltage-dependent calcium channel blockers and excitatory amino acid antag onists, knowledge concerning the influence of an esthetic agents on the ischemic brain remains cru cial for at least two reasons. First, during numerous neurologic and cardiovascular surgical procedures that require anesthesia, the risk of cerebral isch emia remains. It is thus important to identify the potential beneficial and/or detrimental effects of an esthetics. Second, laboratory investigations con- cerning the pathomechanisms of cerebral ischemia often require anesthesia. Such agents might interact either with the ischemic insult itself or with other pharmacologic agents being investigated for their therapeutic potential.
Barbiturates have traditionally been thought to favorably influence outcome from focal ischemia by substantially reducing CMR (Michenfelder and Theye, 1973) . The reduction in CMR is dose depen dent until the EEG develops a pattern of burst sup-pression (Michenfelder, 1974) . Although few out come studies are available demonstrating that pro tection is also dose dependent, it has been presumed that maximal protection will be achieved when maximal CMR reduction is obtained. How ever, the long elimination half-life characteristic of most barbiturates becomes relevant when sufficient doses are administered to produce EEG burst sup pression. This results in a prolonged obtundation of the patient, thereby prohibiting neurologic evalua tion (Nussmeier et aI., 1986) . Because of this as well as hemodynamic and respiratory effects, barbitu rates are not routinely administered, even in situa tions where the threat of cerebral ischemia is sig nificant.
In 1983, it was reported that administration of isoflurane in clinically relevant doses was capable of reducing CMR as effectively as barbiturates (Newberg et aI., 1983) . This agent, which is rela tively insoluble in body tissues (Eger, 1974) , per mits a rapid return to consciousness even from doses sufficient to produce prolonged EEG burst suppression. Based upon the hypothesis that barbi turates reduce ischemic injury by balancing a reduc tion in metabolic demand with a reduction in sub strate delivery, it seemed reasonable to conclude that isoflurane should provide protection under conditions where barbiturates are also efficacious.
This premise was soon tested in the laboratory. Nehls et al. (1987) compared the histologic and neu rologic outcome from 6 h of MCAO in baboons anesthetized with either thiopental, isoflurane, or fentanyl/nitrous oxide. Thiopental and isoflurane doses were manipulated to produce EEG burst sup pression. Surprisingly, while thiopental-treated ba boons did have improved outcome relative to those receiving fentanyl/nitrous oxide, those receiving isoflurane did not. Similarly, Gelb et al. (1989) pro duced in monkeys anes thetized with either halothane or isoflurane. Sys temic hypotension (MABP = 50 mm Hg; induced with sodium nitroprusside in the halothane group or increased concentrations of isoflurane in the isoflu rane group) was superimposed on the vascular oc clusion. No difference in neurologic or neuropatho logic outcome was observed for the two groups, indicating no protective effect for isoflurane.
The above studies can be criticized on separate counts. In the study by Nehls et al. (1987) , blood pressure was different between the anesthetic groups. For example, MABP was 15-20 mm Hg less in those baboons anesthetized with isoflurane as op posed to thiopental. Perfusion pressure has been demonstrated to influence both the area of tissue at risk for infarction as well as the volume of tissue actually infarcted (Drummond et al., 1989; Cole et al., 1990a,b) . Thus, it can be argued that the differ ing blood pressure effects of isoflurane and thiopen tal influenced outcome. In the case of Gelb et al. (1989) , no groups were included in which protection could be demonstrated, thus allowing the possibility that the ischemic insult was too severe for any agent to reduce injury. This latter argument can also be applied to results reported by Milde et al. (1988) , who observed no difference in outcome from MCAO in monkeys receiving either deep isoflurane or thiopental anesthesia. The mortality rate in that study was 47%, suggesting that again the insult was too severe to discriminate any anesthetic-mediated protection.
The current study was designed to determine, in the rat, if the pattern of anesthetic protection ob served by Nehls et al. (1987) could be replicated. In this context, blood pressure was strictly controlled by nonpharmacologic means (i.e., infusion or with drawal of small quantities of blood). The spontane ously hypertensive rat was chosen as the experi mental animal for several reasons. First, pilot stud ies in our own lab, as well as work performed elsewhere, have indicated that variability of infarct volume is reduced in this strain as opposed to that seen in nonhypertensive rats (Brint et al., 1988) . Second, the rat allowed utilization of autoradio graphic determination of CBF. We felt that the re gional resolution offered by this technique would allow appropriate conclusions to be drawn with re spect to intraischemic distribution of blood flow as a function of anesthetic regimen.
As detailed above, infarct volume with metho hexital anesthesia was less than that observed with either halothane of isoflurane. Thus, when criti cisms of the findings of Nehls et al. (1987) and Gelb et al. (1989) are met, the conclusion persists that isoflurane does not protect as fully (if at all) against focal ischemic injury as do the barbiturates. It is of some concern, however, that while rats in all groups exhibited neurologic deficits, no neurologic differences between anesthetic groups were ob served. This may indicate that the neurologic assay employed was nonspecific for the size of infarct quantitated. This is supported by the absence of correlation between infarct volume and neurologic score for individual rats.
Because infarct volumes were decreased with methohexital but not isoflurane (relative to halo thane), we then sought to determine if the area of tissue at risk for ischemia was increased by isoflu rane owing to cerebrovascular steal. Favorable re distribution of CBF by barbiturates administered during focal ischemia has been reported (Branston J Cereb Blood Flow Me/ab, Vol. 11, No.5, 1991 No.5, et al., 1979 Feustel et al., 198 1; Ochiai et al., 1982) . Because isoflurane decreases cerebrovascular re sistance (Cucchiara et al., 1974) , it might reduce blood flow through high-resistance circuits by va sodilating normal vasculature, i.e., by causing a steal phenomenon. This was, however, not found to be the case. On a macroscopic level, blood flow in all ROIs remained greater in isoflurane-anesthe tized rats. We then defined 25 ml/lOO g/min as being a reasonable flow threshold for infarction in the rat (Tyson et al., 1984; Zhou et al., 1988) . Throughout the distribution of the MCA in the cortex and in the more rostral levels of the subcortex (representing primarily the basal ganglia), more tissue was at risk for infarction by these flow criteria in rats receiving methohexital as opposed to isoflurane anesthesia. This finding suggests that in spite of the similar met abolic rate effects of isoflurane and methohexital, ischemic flow thresholds for infarction must be dif ferent for the two agents.
We are left with two interrelated questions: Why do barbiturates protect from focal ischemia and why does isoflurane not provide similar protection? Because isoflurane results in the same degree of metabolic suppression as the barbiturates (Newberg et al., 1983; Warner et al., 1989; Archer et al., 1990) , it seems unlikely that CMR suppression by itself is a sufficient explanation for the cerebral pro tection produced by barbiturates. There are other examples of this situation. Perhaps the best con cerns hypothermic brain protection. For decades, the protective effects of profound hypothermia have been known and have been thought to be re lated to the well-documented metabolic depression that it produces. However, recent work casts some doubt on this hypothesis. For example, studies have shown that relatively small reductions in tem perature (which should have CMR-depressant ef fects much smaller than those seen with high-dose barbiturates) can have dramatic protective effects (Busto et al., 1987; Minamisawa et ai., 1989; Natale and D ' Alecy, 1989) . The mechanism for such ef fects remains unknown, but may be related to at tenuation of ischemia-related neurotransmitter re lease (Busto et al., 1989) . Another example is that of dizocilpine (MK-80l), which has repeatedly been shown to have protective properties during focal ischemia (Oyzuart et al., 1988; Park et ai., 1988a,b; Dirnagl et al., 1990) . However dizocilpine, which has anesthetic properties when given in therapeutic doses, has little effect on CMR in most regions and in some regions CMR is actually increased (Oyzuart et al., 1988; Park et al., 1988a,b) .
There is other information concerning potential interactions between barbiturates and neuronal death. In cell culture models, barbiturates isoflurane is as yet unevaluated-have been dem onstrated to reduce both glutamate and aspartate neurotoxicity (Olney et aI., 1986; Weiss and Choi, 1988; Frandsen et aI., 1990) . While this mechanism might account in part for the beneficial effect of barbiturates, preliminary reports indicate that both halothane and isoflurane are more effective antag onists of glutamate-operated channels than are the barbiturates (Yang and Zorumski, 1989 ). Another potential mechanism described for barbiturate pro tection is free radical scavenging (Smith et aI., 1980) . Finally, barbiturates have been demon strated to provide substantial protection against x irradiation directed toward the head (Olson et aI., 1990) . This effect has been strongly associated with the ,),-aminobutyrate-ergic properties of barbitu rates. Current evidence indicates profound in creases in intraischemic extracellular concentra tions of ,),-aminobutyrate (Shimada et aI., 1990) , providing yet another potential mechanism for bar biturate protection.
In summary, spontaneously hypertensive rats re ceived either deep isoflurane, halothane, or metho hexital anesthesia. The MCA was then occluded for 2 h. Mean infarct volume, assessed after 96 h of reperfusion, was not different between the halo thane or isoflurane groups but was less in those rats receiving methohexital. In a second experiment, CBF was assayed 1 h after MCAO in rats receiving isoflurane or methohexital anesthesia. While flow was significantly reduced in both groups when com pared with sham controls, flow in the areas distal to the occlusion was greater during isoflurane anesthe sia. Similarly, the area of tissue at risk for infarc tion, as defined by flow values of <25 ml/lOO g/min, was less in the isoflurane group. Thus, a cerebro vascular steal during isoflurane anesthesia could not be identified. These results indicate that reduc tion of CMR is not a sufficient criterion for anes thetic-mediated brain protection. The lesser cere bral infarct volume observed in methohexital treated rats, despite an apparently greater quantity of tissue at risk for infarction, suggests that critical ischemic flow thresholds are different for the two anesthetic agents.
